Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.

@article{Terashima2015BloodNT,
  title={Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.},
  author={Takeshi Terashima and Tatsuya Yamashita and Noriho Iida and Taro Yamashita and Hidetoshi Nakagawa and Kuniaki Arai and Kazuya Kitamura and Takashi Kagaya and Yoshio Sakai and Eishiro Mizukoshi and Masao Honda and Shuichi Kaneko},
  journal={Hepatology research : the official journal of the Japan Society of Hepatology},
  year={2015},
  volume={45 9},
  pages={
          949-959
        }
}
AIM Inflammation plays a critical role in cancer. The aim of the present study was to investigate the impact of neutrophil to lymphocyte ratio (NLR) on patients with advanced hepatocellular carcinoma (HCC) treated with hepatic arterial infusion chemotherapy (HAIC). METHODS We retrospectively evaluated 266 patients with advanced HCC treated with HAIC between March 2003 and December 2012. NLR was calculated from the differential leukocyte count by dividing the absolute neutrophil count by the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…